CME Group Inc. [NASDAQ: CME] jumped around 0.98 points on Thursday, while shares priced at $173.18 at the close of the session, up 0.57%. The company report on August 20, 2020 that CME Group to Launch New South American Soybean (Platts) Futures Contract on September 21.
CME Group, the world’s leading and most diverse derivatives marketplace, today announced it will launch South American Soybean (Platts) Futures on September 21, 2020, pending all relevant regulatory review periods. This contract will offer market participants a new tool to directly manage exposure to the Brazilian soybean market.
“As Brazil has emerged as a leading producer and exporter of soybeans, regional pricing alternatives have become increasingly important for risk management,” said Tim Andriesen, CME Group Managing Director of Agricultural Products. “Customers have been using our benchmark grain and oilseed products to hedge their global soybean positions for over 80 years, and these new contracts will enhance those products with contracts that reflect Brazilian export prices.”.
CME Group Inc. stock is now -13.72% down from its year-to-date (YTD) trading value. CME Stock saw the intraday high of $173.93 and lowest of $170.55 per share. The company’s 52-week high price is 225.36, which means current price is +31.40% above from all time high which was touched on 02/27/20.
Compared to the average trading volume of 1.93M shares, CME reached a trading volume of 1051174 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about CME Group Inc. [CME]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for CME shares is $178.39 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on CME stock is a recommendation set at 2.40. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Keefe Bruyette have made an estimate for CME Group Inc. shares, keeping their opinion on the stock as Underperform, with their previous recommendation back on April 14, 2020. The new note on the price target was released on March 30, 2020, representing the official price target for CME Group Inc. stock. Previously, the target price had yet another raise from $214 to $233, while UBS kept a Buy rating on CME stock.
The Average True Range (ATR) for CME Group Inc. is set at 3.36, with the Price to Sales ratio for CME stock in the period of the last 12 months amounting to 12.00. The Price to Book ratio for the last quarter was 2.31, with the Price to Cash per share for the same quarter was set at 4.21. Price to Free Cash Flow for CME in the course of the last twelve months was 59.47 with Quick ratio for the last quarter at 1.00.
How has CME stock performed recently?
CME Group Inc. [CME] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 2.13. With this latest performance, CME shares gained by 1.69% in over the last four-week period, additionally sinking by -17.07% over the last 6 months – not to mention a drop of -17.87% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for CME stock in for the last two-week period is set at 58.48, with the RSI for the last a single of trading hit 64.01, and the three-weeks RSI is set at 55.10 for CME Group Inc. [CME]. The present Moving Average for the last 50 days of trading for this stock 168.59, while it was recorded at 173.05 for the last single week of trading, and 187.94 for the last 200 days.
CME Group Inc. [CME]: Deeper insight into the fundamentals
Operating Margin for any stock indicates how profitable investing would be, and CME Group Inc. [CME] shares currently have an operating margin of +49.61 and a Gross Margin at +79.08. CME Group Inc.’s Net Margin is presently recorded at +43.37.
Return on Total Capital for CME is now 7.95, given the latest momentum, and Return on Invested Capital for the company is 7.03. Return on Equity for this stock inclined to 8.13, with Return on Assets sitting at 2.77. When it comes to the capital structure of this company, CME Group Inc. [CME] has a Total Debt to Total Equity ratio set at 16.84. Additionally, CME Total Debt to Total Capital is recorded at 14.41, with Total Debt to Total Assets ending up at 5.84. Long-Term Debt to Equity for the company is recorded at 16.65, with the Long-Term Debt to Total Capital now at 14.25.
Reflecting on the efficiency of the workforce at the company, CME Group Inc. [CME] managed to generate an average of $485,436 per employee. Receivables Turnover for the company is 9.34 with a Total Asset Turnover recorded at a value of 0.06.CME Group Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.00 and a Current Ratio set at 1.00.
Earnings analysis for CME Group Inc. [CME]
With the latest financial reports released by the company, CME Group Inc. posted 1.9/share EPS, while the average EPS was predicted by analysts to be reported at 1.76/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 8.00%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for CME. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for CME Group Inc. go to 4.05%.
Insider trade positions for CME Group Inc. [CME]
There are presently around $53,085 million, or 87.70% of CME stock, in the hands of institutional investors. The top three institutional holders of CME stocks are: CAPITAL WORLD INVESTORS with ownership of 34,747,815, which is approximately -0.514% of the company’s market cap and around 0.20% of the total institutional ownership; VANGUARD GROUP INC, holding 29,116,340 shares of the stock with an approximate value of $5.04 billion in CME stocks shares; and BLACKROCK INC., currently with $4.72 billion in CME stock with ownership of nearly 2.392% of the company’s market capitalization.
Positions in CME Group Inc. stocks held by institutional investors increased at the end of July and at the time of the July reporting period, where 506 institutional holders increased their position in CME Group Inc. [NASDAQ:CME] by around 18,543,654 shares. Additionally, 468 investors decreased positions by around 21,769,187 shares, while 158 investors held positions by with 266,215,465 shares. The mentioned changes placed institutional holdings at 306,528,306 shares, according to the latest SEC report filing. CME stock had 102 new institutional investments in for a total of 1,877,425 shares, while 76 institutional investors sold positions of 948,233 shares during the same period.